Keith Crandell insider trades
Open-market stock purchases and sales by Keith Crandell, 10% Owner at Boundless Bio, Inc, from SEC Form 4 filings since Oct 26, 2015.
Track record: 0% of 6 scored buys are up 5% or more since purchase, averaging -68%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | BOLD Boundless Bio, Inc | Bought (not open market) | $16.5K |
| Jul 1, 2026 | BOLD Boundless Bio, Inc | Sold | $39.8K |
| Jul 1, 2026 | BOLD Boundless Bio, Inc | Bought (not open market) | — |
| Jun 11, 2026 | MASS 908 Devices Inc | Bought (not open market) | — |
| Jun 11, 2026 | MASS 908 Devices Inc | Bought (not open market) | — |
| Jun 10, 2026 | MASS 908 Devices Inc | Bought (not open market) | — |
| Feb 5, 2026 | TWST Twist Bioscience Corp | Bought (not open market) | — |
Companies traded
- BOLD Boundless Bio, Inc: 2 buys, 1 sale, last Jul 1, 2026
- MASS 908 Devices Inc: 1 buy, last Jun 11, 2026
- TWST Twist Bioscience Corp: 2 buys, 5 sales, last Feb 5, 2026
- SANA Sana Biotechnology, Inc: 2 buys, last Feb 8, 2024
- DALS DA32 Life Science Tech Acquisition Corp: 1 buy, last Jul 28, 2023
- QTRX Quanterix Corp: 1 buy, 3 sales, last Apr 3, 2023
- IOTS ADESTO TECHNOLOGIES Corp: 1 buy, last Jun 4, 2019